What Terpenes Are Actually in Cannabis — and Do They Matter?
Terpenes/Terpenoids in Cannabis: Are They Important?
Systematic analysis of 108 cannabis cultivars reveals beta-caryophyllene and myrcene as the most consistent terpenes. The analytical chemistry is solid; the therapeutic claims remain largely unproven in humans.
By 2020, the cannabis industry had a terpene obsession. Dispensary menus listed terpene profiles alongside THC percentages. Products were marketed by dominant terpenes. Consumers were told that myrcene meant sedation, limonene meant energy, and linalool meant relaxation. The entourage effect — popularized by Russo's 2011 review — had been translated into a marketing doctrine: terpenes drive the cannabis experience.
But the actual science was thinner than the marketing implied. How much of each terpene does cannabis actually contain? Which terpenes appear consistently across cultivars, and which are rare? And what does the analytical chemistry say about whether these compounds exist in quantities sufficient to produce the effects they're credited with?
Lumír Hanuš — the Czech analytical chemist who had co-discovered anandamide in 1992 and reported noladin ether in 2001 — turned his GC-MS expertise to a question that the industry was answering with confidence but science was answering with shrugs: are terpenes in cannabis actually important?
The Analytical Approach
This wasn't a theoretical review like Russo's. Hanuš and his colleague Yotam Hod at Lumir Lab in Jerusalem took the analytical chemistry approach: measure what's actually there.
What's Actually in the Plant
The most important finding was empirical: which terpenes dominate cannabis consistently, across dozens of cultivars.
Beta-caryophyllene and beta-myrcene
were the two most prevalent terpenes across all 108 chemotypes analyzed. Both appeared in the top 10 terpenes in over 80 samples each. This makes them the backbone of the cannabis terpene profile — the two compounds most likely to be present in meaningful concentrations regardless of the specific cultivar.
Other common terpenes — alpha-pinene, limonene, beta-pinene, linalool — appeared frequently but with more variation between chemotypes.
Hanuš & Hod (2020), Med Cannabis Cannabinoids 3:25-60
The dominance of beta-caryophyllene is significant because it is the only terpene proven to directly bind a cannabinoid receptor. It's a selective CB2 agonist — confirmed by Gertsch et al. in 2008 — making it both a terpene and a functional cannabinoid. If any terpene in cannabis contributes to the entourage effect through direct receptor interaction, beta-caryophyllene is the strongest candidate.
The dominance of myrcene matters for a different reason. Myrcene is the terpene most associated with sedation in popular cannabis culture — the "couch lock" molecule. It's analgesic, anti-inflammatory, and a muscle relaxant in animal models. Its consistent prevalence across cultivars means it's the terpene most consumers are actually exposed to in meaningful amounts.
The Six That Matter Most
The Honest Assessment
Hanuš and Hod reviewed the biological activity literature for each terpene and arrived at a nuanced conclusion: terpenes are pharmacologically active, probably therapeutically important, and insufficiently studied.
The paper's title asks a question: "Are they important?" The authors' answer is qualified: probably yes, but we don't have enough human data to say definitively. The analytical chemistry shows terpenes are consistently present. The preclinical pharmacology shows they're biologically active. The clinical evidence for their role in the cannabis experience remains largely theoretical.
What This Means for Consumers
Myth vs. Reality
You should choose cannabis products based primarily on their terpene profile because terpenes determine the experience.
Terpene profiles provide useful information about aroma and flavor, and they may contribute to effects, but the evidence that specific terpenes reliably predict specific experiences is weak. THC and CBD content, the THC:CBD ratio, dose, route of administration, and individual biology are far more established predictors of cannabis effects than terpene profiles. Using terpene data to find products you enjoy is reasonable — using it to predict specific therapeutic outcomes is premature.
The Evidence
Hanuš & Hod (2020) documented significant terpene variation across 108 chemotypes but noted that 'only few studies have pharmacology' sufficient for therapeutic conclusions in humans. Santiago et al. (2020) found no terpene activity at CB1/CB2. No clinical trial has validated terpene-based product selection.
Hanuš & Hod (2020), Med Cannabis Cannabinoids 3:25-60
The practical takeaway: terpenes are real compounds with real pharmacology, but the cannabis industry has outpaced the science in its claims about what they do. Beta-caryophyllene's CB2 activity is confirmed. Everything else is promising preclinical data that hasn't been validated in humans. For a full guide to what the science supports, see our article on terpenes explained.
Hanuš: The Analyst Returns
Lumír Hanuš was 77 years old when this paper was published. His career had traced an extraordinary arc through cannabinoid science — from co-discovering the first endocannabinoid in 1992 to reporting a disputed third endocannabinoid in 2001, and now to systematically cataloging the terpene chemistry of 108 cannabis cultivars.
Throughout, his contribution was always the same: precise analytical chemistry. Hanuš was the person who could extract, purify, and identify vanishingly small quantities of bioactive molecules from complex biological mixtures. The technique that found anandamide in pig brain worked just as well for finding beta-caryophyllene in cannabis flowers.
His lab, Lumir Lab (named after himself), was based at the Hebrew University Biotechnology Park — the same campus where he had worked with Raphael Mechoulam for three decades. By 2020, his focus had shifted from discovery to characterization: not finding new molecules, but rigorously documenting what the cannabis plant actually contains and what those contents might do.
Frequently Asked Questions
Cite this study
Hanuš LO, Hod Y. (2020). Terpenes/Terpenoids in Cannabis: Are They Important?. Med Cannabis Cannabinoids. https://doi.org/10.1159/000509733